Skip to main navigation Skip to search Skip to main content

Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein

  • K. Raviprakash*
  • , T. J. Kochel
  • , D. Ewing
  • , M. Simmons
  • , I. Phillips
  • , C. G. Hayes
  • , K. R. Porter
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Abstract

Recombinant plasmid DNA constructs expressing truncated or full-length dengue-1 envelope (E) with or without the pre-membrane (prM) were tested for immunogenicity in mice, as candidate dengue DNA vaccines. Two plasmids, one expressing the N-terminal 80% E and the other expressing prM and full length E were immunogenic in intradermally inoculated mice. The vaccinated mice produced dengue-1 specific antibodies that were both neutralizing and long lasting. Data suggested that the plasmid expressing prM and full length E produced virus like particles in transfected cells, and is probably a better immunogen compared to that expressing 80% E. Copyright (C) 2000 Elsevier Science Ltd.

Original languageEnglish
Pages (from-to)2426-2434
Number of pages9
JournalVaccine
Volume18
Issue number22
DOIs
StatePublished - May 2000

Keywords

  • Antibody response
  • DNA vaccine
  • Dengue virus
  • Mouse

Fingerprint

Dive into the research topics of 'Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein'. Together they form a unique fingerprint.

Cite this